Christopher Tretter
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
-
- Renal cell carcinoma treatment
Papers in
- Co-authors
- Janice P. Dutcher (2 shared papers)Walter J. Urba (2 shared papers)Geoffrey R. Weiss (2 shared papers)Kim Margolin (2 shared papers)Theodore F. Logan (2 shared papers)Jeffrey A. Sosman (2 shared papers)Joseph I. Clark (2 shared papers)Michael B. Atkins (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Journal of Chemotherapy (1 paper)Clinical Immunology (1 paper)The Prostate (1 paper)Clinical Genitourinary Cancer (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Christopher Tretter
11 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Cancer Research 381
- Pulmonary and Respiratory Medicine 668
- Oncology 429
- Surgery 361
- Urology 50
Countries citing papers authored by Christopher Tretter
This map shows the geographic impact of Christopher Tretter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Tretter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Tretter more than expected).
Fields of papers citing papers by Christopher Tretter
This network shows the impact of papers produced by Christopher Tretter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Tretter. The network helps show where Christopher Tretter may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Tretter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2004 | 598 |
| 2 | 2003 | 209 | |
| 3 | 2014 | 184 | |
| 4 | 2007 | 42 | |
| 5 | 2006 | 16 | |
| 6 | 2004 | 16 | |
| 7 | 2016 | 9 | |
| 8 | 2005 | 7 | |
| 9 | 2003 | 4 | |
| 10 | 2013 | 1 | |
| 11 | 2005 | 1 | |
| 12 | Value of 18F-FDG in the assessment of patients with upper tract urothelial carcinoma | 2011 | 0 |
About Christopher Tretter
Christopher Tretter is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Immunology and Epidemiology, having authored 12 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (4 papers), Immunotherapy and Immune Responses (3 papers), Urinary and Genital Oncology Studies (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Adrenal and Paraganglionic Tumors (2 papers), T-cell and B-cell Immunology (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Cancer Research (381 citations), Pulmonary and Respiratory Medicine (668 citations), Oncology (429 citations), Surgery (361 citations) and Urology (50 citations). Christopher Tretter has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Janice P. Dutcher, Walter J. Urba, Geoffrey R. Weiss, Kim Margolin, Theodore F. Logan, Jeffrey A. Sosman, Joseph I. Clark, Michael B. Atkins, Michael S. Gordon and John W. Smith. Their work appears in journals such as Journal of Clinical Oncology, Journal of Chemotherapy, Clinical Immunology, The Prostate and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.